Compare Suparma Tbk. (SPMA) vs Reksa Dana Indeks KISI IDX30 ETF (XKID) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Suparma Tbk. vs Reksa Dana Indeks KISI IDX30 ETF — how do they compare? Suparma Tbk. trades at Rp170 (market cap 705.25B, 84.5K 24h volume), while Reksa Dana Indeks KISI IDX30 ETF trades at Rp800 (market cap 9.44B). The key difference: Suparma Tbk. is far larger — about 74.7× Reksa Dana Indeks KISI IDX30 ETF's market cap. Which is the better fit depends on your goals.
| SPMA | XKID | |
|---|---|---|
Market Cap | 705.25B | 9.44B |
Volume | 84.5K | — |
Lot | 845 | — |
Turnover | 14.37M | — |
Average Price | 170.08 | — |
Value | 14.37M | — |
Indicative Equilibrium Price | 170 | — |
Indicative Equilibrium Volume | 1 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Suparma Tbk.
PT Suparma Tbk (Entity) was established under the Domestic Capital Investment Law No. 6 of 1968 as amended by Law No. 12 of 1970 based on the Notarial Deed No. 29 of Tjahjadi Hartanto, S.H., on August 25, 1976. The Entity's name, PT Supar Inpama was changed to PT Suparma based in the Notarial Deed No. 5 dated December 7, 1978 of the same notary.
Read more on SPMA →
